Family Medicine · Indianapolis, IN
NPI
1548421985
Since 2008
Specialty
Family Medicine
Code 207Q00000X
Group practices
17
Medicare group memberships
Hospitals
5
Hospital affiliations
1402 E County Line Rd
Indianapolis, IN, 46227
Phone (317) 887-7805
Groups this clinician bills Medicare through
Medicare paid, 2024
$337K
4,239 services
Medicare patients, 2024
1,487
Average age 76
Drug cost, 2024
$7.2M
90,897 prescriptions
Company payments, 2025
$3,289
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pragneshkumar N Radadiya was code 99308 (snf e&m), 1,020 times for 487 patients. In total Pragneshkumar N Radadiya billed 4,239 services in 24 codes, and Medicare paid $337K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-05-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Office | 1,020 | 487 | $52.52 | $54K |
| 99306 SNF E&M | Facility | 782 | 626 | $131.71 | $103K |
| 99309 SNF E&M | Office | 615 | 371 | $79.61 | $49K |
| 99233 Hospital E&M - Subsequent | Facility | 392 | 206 | $86.52 | $34K |
| 99232 Hospital E&M - Subsequent | Facility | 364 | 173 | $56.45 | $21K |
| 99308 SNF E&M | Facility | 348 | 219 | $50.83 | $18K |
| 99309 SNF E&M | Facility | 245 | 209 | $79.66 | $20K |
| 99239 Hospital Discharge Management | Facility | 243 | 231 | $82.66 | $20K |
| 99223 Hospital E&M - Initial | Facility | 61 | 61 | $122.54 | $7,475 |
| 99497 Care Management/Coordination | Facility | 44 | 44 | $55.79 | $2,455 |
| 99222 Hospital E&M - Initial | Facility | 23 | 23 | $91.38 | $2,102 |
| 99231 Hospital E&M - Subsequent | Facility | 23 | 15 | $32.79 | $754 |
| 99306 SNF E&M | Office | 21 | 20 | $134.08 | $2,816 |
| 99348 Home E&M - New and Established | Office | 18 | 18 | $57.01 | $1,026 |
By year: 2022 $391K for 5,445 services; 2023 $321K for 4,130 services; 2024 $337K for 4,239 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pragneshkumar N Radadiya prescribed most often to Medicare patients was Atorvastatin Calcium, with 4,622 prescriptions and refills. In total Pragneshkumar N Radadiya wrote 90,897 Medicare prescriptions that cost $7.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 4,622 | 4,630 | 640 | $58K |
| Eliquis Apixaban | 3,360 | 3,363 | 306 | $1.0M |
| Levothyroxine Sodium Generic | 2,958 | 2,958 | 368 | $36K |
| Furosemide Generic | 2,585 | 2,585 | 420 | $17K |
| Sertraline Hcl Generic | 2,569 | 2,572 | 378 | $27K |
| Gabapentin Generic | 2,276 | 2,276 | 331 | $37K |
| Potassium Chloride Generic | 2,024 | 2,025 | 324 | $58K |
| Amlodipine Besylate Generic | 1,919 | 1,919 | 302 | $15K |
| Pantoprazole Sodium Generic | 1,863 | 1,863 | 313 | $31K |
| Trazodone Hcl Generic | 1,768 | 1,768 | 297 | $18K |
| Tamsulosin Hcl Generic | 1,752 | 1,752 | 262 | $30K |
| Metoprolol Tartrate Generic | 1,537 | 1,540 | 236 | $13K |
| Omeprazole Generic | 1,534 | 1,534 | 276 | $19K |
| Donepezil Hcl Generic | 1,522 | 1,522 | 204 | $25K |
| Lisinopril Generic | 1,498 | 1,498 | 242 | $14K |
Brand drugs: 14,091 claims; generic drugs: 76,325 claims; opioid claims: 251.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pragneshkumar N Radadiya $3,289 ($3,289 in general payments such as food, travel and fees) from 5 companies. The largest payer was Lilly USA, LLC with $3,150.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 3 | $3,150 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $50.41 |
| Scpharmaceuticals Inc. SCPH | 1 | $47.62 |
| Merck Sharp & Dohme LLC MRK | 1 | $27.09 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $13.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.